Good morning, everyone, and thank you for joining us to review NovoCure's third-quarter 2021 performance. Other members of the executive leadership team are also on the call and available for Q&A. The slides presented today can be view on our website, www.novocure.com, by clicking on the link for the third-quarter 2021 financial results located in the Event section of our Investor Relations page.
CHX earnings call for the period ending September 30, 2021.
Hello and thank you for joining the Stewart Information Services Third Quarter 2021 Earnings Call. Joining me today are CEO Fred Eppinger and CFO David Hisey. The risks and uncertainties that forward-looking statements are subject to include, but are not limited to, the risks and other factors detailed in our press release published yesterday evening and in the statement regarding forward-looking information, risk factors and other sections of the company's Form 10-K and other filings with the SEC.